SomnoMed Limited (SOM.AX)
AUD 0.43
(0.0%)
AUD 0.43
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 | 69.8 Million AUD | 11.7% |
| 2023 | 62.49 Million AUD | 7.57% |
| 2022 | 58.09 Million AUD | 3.43% |
| 2021 | 56.16 Million AUD | -8.96% |
| 2020 | 61.69 Million AUD | 77.53% |
| 2019 | 34.75 Million AUD | -23.95% |
| 2018 | 45.69 Million AUD | 10.88% |
| 2017 | 41.21 Million AUD | 1.94% |
| 2016 | 40.42 Million AUD | 45.68% |
| 2015 | 27.75 Million AUD | 44.97% |
| 2014 | 19.14 Million AUD | 4.59% |
| 2013 | 18.3 Million AUD | 48.66% |
| 2012 | 12.31 Million AUD | 40.99% |
| 2011 | 8.73 Million AUD | 11.46% |
| 2010 | 7.83 Million AUD | 29.74% |
| 2009 | 6.03 Million AUD | -13.8% |
| 2008 | 7 Million AUD | 49.07% |
| 2007 | 4.69 Million AUD | 15.47% |
| 2006 | 4.06 Million AUD | -48.61% |
| 2005 | 7.91 Million AUD | 1167.43% |
| 2004 | 624.7 Thousand AUD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q4 | 69.8 Million AUD | 0.0% |
| 2024 FY | 69.8 Million AUD | 11.7% |
| 2024 Q2 | 63.91 Million AUD | 0.0% |
| 2023 FY | 62.49 Million AUD | 7.57% |
| 2023 Q4 | 62.49 Million AUD | 0.0% |
| 2023 Q2 | 64.64 Million AUD | 0.0% |
| 2022 Q4 | 58.09 Million AUD | 0.0% |
| 2022 Q2 | 54.17 Million AUD | 0.0% |
| 2022 FY | 58.09 Million AUD | 3.43% |
| 2021 FY | 56.16 Million AUD | -8.96% |
| 2021 Q2 | 58.9 Million AUD | 0.0% |
| 2021 Q4 | 56.16 Million AUD | 0.0% |
| 2020 Q2 | 42.7 Million AUD | 0.0% |
| 2020 Q4 | 61.69 Million AUD | 0.0% |
| 2020 FY | 61.69 Million AUD | 77.53% |
| 2019 Q4 | 34.75 Million AUD | 0.0% |
| 2019 Q2 | 38.57 Million AUD | 0.0% |
| 2019 FY | 34.75 Million AUD | -23.95% |
| 2018 Q2 | 37.43 Million AUD | 0.0% |
| 2018 FY | 45.69 Million AUD | 10.88% |
| 2018 Q4 | 45.69 Million AUD | 0.0% |
| 2017 Q4 | 41.21 Million AUD | 0.0% |
| 2017 Q2 | 42.01 Million AUD | 0.0% |
| 2017 FY | 41.21 Million AUD | 1.94% |
| 2016 Q4 | 40.42 Million AUD | 0.0% |
| 2016 FY | 40.42 Million AUD | 45.68% |
| 2016 Q2 | 29.6 Million AUD | 0.0% |
| 2015 FY | 27.75 Million AUD | 44.97% |
| 2015 Q2 | 27.32 Million AUD | 0.0% |
| 2015 Q4 | 27.75 Million AUD | 0.0% |
| 2014 Q2 | 18.89 Million AUD | 0.0% |
| 2014 Q4 | 19.14 Million AUD | 0.0% |
| 2014 FY | 19.14 Million AUD | 4.59% |
| 2013 FY | 18.3 Million AUD | 48.66% |
| 2013 Q2 | 12.85 Million AUD | 0.0% |
| 2013 Q4 | 16.11 Million AUD | 0.0% |
| 2012 Q4 | 12.31 Million AUD | 0.0% |
| 2012 FY | 12.31 Million AUD | 40.99% |
| 2011 Q4 | 8.73 Million AUD | 0.0% |
| 2011 FY | 8.73 Million AUD | 11.46% |
| 2010 FY | 7.83 Million AUD | 29.74% |
| 2010 Q4 | 7.83 Million AUD | 0.0% |
| 2009 FY | 6.03 Million AUD | -13.8% |
| 2009 Q4 | 6.03 Million AUD | 0.0% |
| 2008 FY | 7 Million AUD | 49.07% |
| 2008 Q4 | 7 Million AUD | 0.0% |
| 2007 Q4 | 4.69 Million AUD | 0.0% |
| 2007 FY | 4.69 Million AUD | 15.47% |
| 2006 FY | 4.06 Million AUD | -48.61% |
| 2006 Q4 | 4.06 Million AUD | 0.0% |
| 2005 FY | 7.91 Million AUD | 1167.43% |
| 2005 Q4 | 7.91 Million AUD | 0.0% |
| 2004 FY | 624.7 Thousand AUD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| 4DMedical Limited | 120.01 Million AUD | 41.837% |
| Adherium Limited | 9.88 Million AUD | -606.014% |
| Aroa Biosurgery Limited | 101.82 Million AUD | 31.444% |
| Atomo Diagnostics Limited | 11.37 Million AUD | -513.451% |
| Anteris Technologies Ltd | 45.7 Million AUD | -52.741% |
| Control Bionics Limited | 9.02 Million AUD | -673.261% |
| CardieX Limited | 12.64 Million AUD | -451.825% |
| Compumedics Limited | 40.35 Million AUD | -72.964% |
| Cochlear Limited | 2.74 Billion AUD | 97.457% |
| CleanSpace Holdings Limited | 26.05 Million AUD | -167.946% |
| Cyclopharm Limited | 45.91 Million AUD | -52.033% |
| EMVision Medical Devices Ltd | 23.97 Million AUD | -191.2% |
| Nova Eye Medical Limited | 29.88 Million AUD | -133.601% |
| HeraMED Limited | 2.95 Million AUD | -2264.583% |
| Imricor Medical Systems, Inc. | 12.17 Million AUD | -473.295% |
| ImpediMed Limited | 46.98 Million AUD | -48.565% |
| InhaleRx Limited | 1.57 Million AUD | -4326.748% |
| LBT Innovations Limited | 7.93 Million AUD | -780.15% |
| Micro-X Limited | 26.89 Million AUD | -159.545% |
| Neurotech International Limited | 12.21 Million AUD | -471.542% |
| OncoSil Medical Limited | 6.71 Million AUD | -939.007% |
| PolyNovo Limited | 109.16 Million AUD | 36.057% |
| Respiri Limited | 6.19 Million AUD | -1027.534% |
| Universal Biosensors, Inc. | 30.12 Million AUD | -131.752% |
| Uscom Limited | 5.13 Million AUD | -1259.49% |
| Visioneering Technologies, Inc. | 11.2 Million AUD | -522.956% |